Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle

Published 2014 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle
Authors
Keywords
-
Journal
ANTIVIRAL RESEARCH
Volume 106, Issue -, Pages 111-115
Publisher
Elsevier BV
Online
2014-04-06
DOI
10.1016/j.antiviral.2014.03.017

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.